Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sodium channel protein type 5 subunit alpha (NaV1.5) is the pore-forming α-subunit of the voltage-gated sodium channel predominantly expressed in cardiac muscle cells. It mediates the rapid influx of sodium ions (Na+) during phase 0 of the cardiac action potential, which is responsible for the fast depolarization and propagation of electrical impulses throughout heart tissue. Mutations in SCN5A are associated with several inherited arrhythmia syndromes.
Directly blocks NaV1.5 activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sodium channel protein type 5 subunit alpha (NaV1.5).